Ofloglee B Ear Drops contain Ofloxacin 0.3% w/v + Beclomethasone 0.025% w/v + Clotrimazole 1% w/v, a triple-action ear drop for bacterial, fungal, and inflammatory ear conditions.
Ofloxacin delivers broad-spectrum antibacterial activity, Clotrimazole provides targeted antifungal therapy, and Beclometasone reduces inflammation and discomfort, ensuring rapid relief and recovery.
Clinically, Ofloglee BC Ear Drops are used in ENT clinics, hospitals, and home care, supporting high patient compliance and effective ear infection management.
From a business perspective, Ofloglee BC Ear Drops strengthen the ear care segment, offering strong prescription demand, repeat sales, and high PCD pharma franchise growth potential at a best price for franchise partners.